1-Oxa-4,9-diazaspiro[5.5]undecan-3-one, 9-[2-(2,5-difluorophenyl)ethyl]-4-ethyl-2-methyl-, hydrochloride (1:1), (2R)-

1-Oxa-4,9-diazaspiro[5.5]undecan-3-one, 9-[2-(2,5-difluorophenyl)ethyl]-4-ethyl-2-methyl-, hydrochloride (1:1), (2R)- Struktur
2535970-65-9
CAS-Nr.
2535970-65-9
Englisch Name:
1-Oxa-4,9-diazaspiro[5.5]undecan-3-one, 9-[2-(2,5-difluorophenyl)ethyl]-4-ethyl-2-methyl-, hydrochloride (1:1), (2R)-
Synonyma:
EST73502 hydrochloride;1-Oxa-4,9-diazaspiro[5.5]undecan-3-one, 9-[2-(2,5-difluorophenyl)ethyl]-4-ethyl-2-methyl-, hydrochloride (1:1), (2R)-
CBNumber:
CB59315762
Summenformel:
C19H27ClF2N2O2
Molgewicht:
388.88
MOL-Datei:
2535970-65-9.mol

1-Oxa-4,9-diazaspiro[5.5]undecan-3-one, 9-[2-(2,5-difluorophenyl)ethyl]-4-ethyl-2-methyl-, hydrochloride (1:1), (2R)- Eigenschaften

storage temp. 
Store at -20°C
Löslichkeit
DMSO : 50 mg/mL (128.57 mM; Need ultrasonic)
Aggregatzustand
Solid
Farbe
White to off-white

Sicherheit

1-Oxa-4,9-diazaspiro[5.5]undecan-3-one, 9-[2-(2,5-difluorophenyl)ethyl]-4-ethyl-2-methyl-, hydrochloride (1:1), (2R)- Chemische Eigenschaften,Einsatz,Produktion Methoden

1-Oxa-4,9-diazaspiro[5.5]undecan-3-one, 9-[2-(2,5-difluorophenyl)ethyl]-4-ethyl-2-methyl-, hydrochloride (1:1), (2R)- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


1-Oxa-4,9-diazaspiro[5.5]undecan-3-one, 9-[2-(2,5-difluorophenyl)ethyl]-4-ethyl-2-methyl-, hydrochloride (1:1), (2R)- Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 3)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
TargetMol Chemicals Inc.

support@targetmol.com United States 38463 58
Shanghai Yifei Biotechnology Co. , Ltd. 021-65675885 18964387627
customer_service@efebio.com China 11974 58
TargetMol Chemicals Inc. 15002134094
marketing@targetmol.cn China 19711 58

  • 1-Oxa-4,9-diazaspiro[5.5]undecan-3-one, 9-[2-(2,5-difluorophenyl)ethyl]-4-ethyl-2-methyl-, hydrochloride (1:1), (2R)-
  • EST73502 hydrochloride
  • 2535970-65-9
  • C19H27ClF2N2O2
Copyright 2019 © ChemicalBook. All rights reserved